from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2609c/-

LFCtreatmentdescriptionclass of inhibitor

-0.172

Amikacinug/mL Amikacintranslation

-2.140

Cap5-10ug/mL Capreomycintranslation

-2.030

Rox10-50 ug/mL Roxithromycintranslation

0.011

SM2-5 ug/mL Streptomycintranslation

-0.633

Tet5-10 ug/mL Tetracyclinetranslation

0.711

Rif0.2-5ug/mL Rifampicintranscription

-0.193

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.841

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.150

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.057

CPZ10-50 ug/mL Chlorpromazinerespiration

0.161

Clofazimine10-13 ug/mL Clofaziminerespiration

0.589

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.769

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.487

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.119

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.441

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.215

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.191

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.085

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.249

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.761

KCN5-20 ug/mL Potassium cyaniderespiration

0.537

NaN30.2-2 mM Sodium aziderespiration

-0.276

Nigericin50 uM Nigericinrespiration

1.252

TRC10-150 ug/mL Triclosanrespiration

-0.596

TRZ10-25 ug/mL Thioridazinerespiration

-2.003

Valinomycin0.5-10 uM Valinomycinrespiration

-0.605

ZnSO42 mM ZnSO4respiration

-0.983

menadione6-10 ug/mL Menadionerespiration

0.332

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.243

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.081

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.373

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.539

NRP_1Non-replicating persistence stage 1dosRassociated

0.012

Amp0.2mg/mL AmpicillincellWall

0.229

Cephalexin20-100 ug/mL CephalexincellWall

-0.337

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.278

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.076

EMB10-20 ug/mL EthambutolcellWall

-0.005

Eta12-40 ug/mL EthionamidecellWall

0.268

INH0.2-0.4 ug/mL IsoniazidcellWall

0.310

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.325

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.146

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.464

BZA0.12 mg/mL BenzamidearomaticAmides

0.089

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.367

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.275

H2O24 mM hydrogen peroxideDNAdamaging

-0.451

Levo10 ug/mL LevofloxacinDNAdamaging

-0.534

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.433

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.385

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.124

UVUV-irradiationDNAdamaging

-0.947

ARP41-4 ug/mL Antitubercular compound ARP4?

0.033

Antimycin12.5-50 ug/mL Antimycin A?

0.302

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.409

PA_110-50 ug/mL Antitubercular compound PA-1?

0.169

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.061

PA8240.2-2 ug/mL PA-824?

0.240

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.417

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.034

Verapamil50 uM Verapamil?

0.569

mercaptoethanol2 mM 2-Mercaptoethanol?

0.347

methoxatin10-20 ug/mL Methoxatin?